|Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)||
The purpose of this funding opportunity announcement (FOA) is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients. This is the reissue of PAR 18-534 and has replaced PAR 18-534.
Expiration February 17, 2022
Information for Researchers
Funding Opportunities for Muscular Dystrophy Research